Indy
Menu ☰
Premium
Strategies Backtester Super Charts Strategies
Consumer Interest
COT Analysis Leaderboards News
Hubs
Politicians Hub Tickers Hub Crypto Hub
Strategies Leaderboards News Pricing
Sign in Register

Congress Trades

Latest disclosures

Chamber Transaction Date Member ▼ Owner Asset Action Amount Ticker Δ Since Trade View
House Sep. 25, 2024 Josh Gottheimer Joint Crinetics Pharmaceuticals, Inc. - Common Stock PURCHASE $1,001 - $15,000 CRNX ▼ -10.43% View
Last updated: Dec 20, 08:25